Floatz logo

Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
lm-2417
Cancer
LaNova Medicines LimitedP1/2CC (40)
lm-24c5
Cancer
LaNova Medicines LimitedP1/2CC (40)
Luvixasertib
Cancer
Treadwell Therapeutics, IncP1/2CC (40)
Mdna11
Cancer
Medicenna Therapeutics, Inc.P1/2CC (40)
mhb036c
Cancer
Minghui Pharmaceutical (Hangzhou) LtdP1/2CC (40)
mhb039a
Cancer
Minghui Pharmaceutical (Hangzhou) LtdP1/2CC (40)
Nemvaleukin Alfa
Cancer
Mural Oncology, IncP1/2CC (40)
Ntx-301
Cancer
Xennials Therapeutics Australia Pty LtdP1/2CC (40)
Nuv-1511
Cancer
Nuvation Bio Inc.P1/2CC (40)
Obi-902
Cancer
OBI Pharma, IncP1/2CC (40)
Obi-992
Cancer
OBI Pharma, IncP1/2CC (40)
Paroxetine
Cancer
BioNTech SEP1/2CC (40)
Ptt-4256
Cancer
Pathios Therapeutics Pty LtdP1/2CC (40)
PULOCIMAB
Cancer
AkesoP1/2CC (40)
Pumitamig
Cancer
BioNTech SEP1/2CC (40)
PURINOSTAT
Cancer
Chengdu Zenitar Biomedical Technology Co., LtdP1/2CC (40)
ql2107
Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (40)
qlc5508
Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (40)
rc118
Cancer
RemeGen Co., Ltd.P1/2CC (40)
rc118-adc
Cancer
RemeGen Co., Ltd.P1/2CC (40)
rc148
Cancer
RemeGen Co., Ltd.P1/2CC (40)
RNK05047
Cancer
Ranok Therapeutics (Hangzhou) Co., Ltd.P1/2CC (40)
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM WHICH COMPRISES A METHIONINASE GENE
Cancer
Guangzhou Sinogen Pharmaceutical Co., LtdP1/2CC (40)
sg001
Cancer
Shanghai Runshi Pharmaceutical Technology Co., LtdP1/2CC (40)
Shr-4375
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P1/2CC (40)
Showing 176 to 200 of 534 assets
PreviousPage 8 of 22Next